Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Kasbah Resources - Exposure to the Tin Market

Kasbah Resources Limited (ASX:KAS) was listed on the Australian Stock Exchange on 27th April 2007 with the objective of bringing the Achmmach tin project in northern Morocco into commercial production. After completing the major evaluation steps and analysis, Kasbah Resources Limited (ASX:KAS) is in the final stages of preparing a definitive feasibility study to develop a 750ktpa underground mine and associated processing facility. Kasbah intends to produce an average of 4,500tpa of tin ore in concentrate (~1.3% of world production) over a 10 year mine life, mining current reserves, with  expectations of extending mine life through further resource conversion.
research_no_image.jpg

A key issue moving through calendar year 2018 will be the source of funding for the construction of Achmmach. As at the time of writing the company has approximately A$3.1M in cash with debt of A$1M owed to its main shareholder Pala Investments.
Assuming all inclusive initial capital costs of ~US$100M and if it can be agreed to by shareholders, JV partners and banks that a 50/50 debt to equity split is practical, then Kasbah would need to raise equity capital of ~US$37.5M (A$48M).

Full report is available via Capital Network website
View full KAS profile View Profile

Kasbah Resources Timeline

Newswire
December 06 2016

Related Researches

no_picture_pai.jpg
June 26 2017

Agreement with a global major: Global major gold miner, Newmont, has recently entered into an agreement with Greatland (GGP.LON) such that Newmont will have access to Greatland’s Ernest Giles gold project for a period of 6 months, and is able to apply their proprietary exploration methods (which, we understand, are ideally suited for identifying large gold systems under cover). Overall, the key point of note for investors is that this commitment from Newmont is a strong validation of the potential exploration upside in Ernest Giles. Typically, global major of this size would be unlikely to be involved in a project unless they saw potential for a large scale resource. News flow from Newmont’s results will be key to Greatland Gold shares over this 6 month period.

no_picture_pai.jpg
June 26 2017

Thor Mining (THR.LON) is an exploration and development company with an advanced tungsten/molybdenum project poised for development; and exciting lithium and tungsten exploration projects. Thor is listed on the Alternative Investment Market (AIM) in London and the Australian Stock Exchange (ASX).

no_picture_pai.jpg
July 31 2017

Medgold Resources Corp. (MED.CVE) is a European-focused TSX-V listed exploration and development company targeting gold properties in central and southern Serbia. The company is run by a highly experienced management team with a successful track record of building value in resource companies. Medgold is aiming to become a leading European gold company.

REASONS TO CONSIDER MEDGOLD (MED.CVE)

Serbian near surface targets: Medgold (MED.CVE) possesses significant acreage in the highly prospective exploration regions of Central and Southern Serbia. Medgold has already seen encouraging near-surface results for precious metals in underexplored regions of the Serbo-Macedonia Belt for precious metals (e.g. 40m sawedchannel sample @ 8.3 g/t Au)

A well-funded exploration program: The company has a well-funded exploration program, achieved through a savvy alliance and option agreement with a larger partner (TSX- and NYSE-listed silver producer, Fortuna Silver Mines @US$750m mkt cap). This significantly reduces the potential risk of unknown equity dilution for prospective shareholders, as the potential asset/project dilution is very clearly defined through the option agreements. Furthermore, the optioning of some of the Serbian targets (as well as the direct equity ownership stake of 24% in Medgold) by Fortuna, provides investors with strong validation that Medgold’s exploration ground looks prospective.

The best of both worlds: Smaller gold exploration companies generally tend to fall into two buckets. Either with exploration assets which are outcropping/near surface and high grade; but located in relatively unstable, ‘frontier’ countries. Or with lower grade, deep cover exploration targets, but located in stable jurisdictions. A key feature of Medgold for potential investors, is that it is targeting the near surface, high grade deposits, but also is located in a stable and well-understood jurisdiction and results from the Tlamino Project demonstrate this point. Thus we would consider it attractively placed versus peers on a risk-reward basis.

Focused management: Medgold is in the process of disposing of its Portuguese exploration assets to focus on the highly prospective Serbian assets; where management is increasingly looking to both further define existing explorations targets, and also expand the company’s land holdings. Too often one sees mineral exploration companies spend too much time and too much cash on trying to get results out of land holdings; and we like that Medgold management have shown the discipline to cut assets when they believe the potential upside has become limited.

What to watch for: Newsflow on positive exploration results in Serbia will be a key share price driver.

ASSETS, SERBIA

Medgold Resources Corp. is a European-focused TSX-V listed exploration and development company targeting gold properties in central and southern Serbia. The company is run by a highly experienced management team with a successful track record of building value in resource companies. Medgold is aiming to become a leading European gold company.

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use